S.Res. 770

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 770 Agreed to Senate (ATS)]

<DOC>

119th CONGRESS
2d Session
S. RES. 770

Designating June 6, 2026, as National Naloxone Awareness Day.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

June 15, 2026

Mr. Scott of Florida (for himself, Mr. Markey, Ms. Cantwell, Mr. 
Tillis, Mr. Blumenthal, Mrs. Capito, Mr. Whitehouse, Ms. Klobuchar, Mr. 
Risch, Mr. King, Mr. Heinrich, Mr. Wyden, Mr. Booker, Mr. Bennet, Mr. 
Lankford, Mrs. Moody, Mr. Justice, and Ms. Cortez Masto) submitted the 
following resolution; which was considered and agreed to

_______________________________________________________________________

RESOLUTION

Designating June 6, 2026, as National Naloxone Awareness Day.

Whereas opioid overdoses continue to devastate communities across the United 
States, leading to a significant loss of life and widespread societal 
impact;
Whereas opioid overdoses during the 12 months preceding November of 2025 claimed 
a reported 43,810 lives in the United States;
Whereas fatal overdoses are often witnessed by a bystander;
Whereas, in 2025 alone, the Drug Enforcement Administration seized more than 
369,000,000 potentially deadly doses of fentanyl, enough to kill every 
individual in the United States;
Whereas, according to data from the Centers for Disease Control and Prevention, 
fentanyl-related poisonings are a leading cause of death for individuals 
in the United States between 18 and 44 years of age;
Whereas naloxone is a safe and effective medication that can reverse opioid 
overdoses and save lives when administered promptly by rapidly reversing 
the effects of opioids;
Whereas naloxone plays a vital role in preventing long-term brain damage and 
reducing the risk of fatality associated with opioid overdoses;
Whereas the Centers for Disease Control and Prevention recognizes naloxone as an 
important tool in preventing opioid overdose deaths;
Whereas it is imperative to educate individuals, families, healthcare 
professionals, and first responders about--

(1) the benefits of naloxone, including the potential naloxone has to 
reduce opioid-related fatalities; and

(2) how to safely administer naloxone;

Whereas it is imperative to identify current or potential barriers for 
individuals, organizations, and Federal, State, and local governments to 
obtain and distribute naloxone;
Whereas increasing access to naloxone can improve the chances of recovery for 
individuals struggling with opioid use disorder and support a future 
free from the grip of opioid use disorder;
Whereas the Food and Drug Administration acted to authorize the over-the-counter 
sale of 10 milligram doses of naloxone alongside extending the shelf 
life of newly manufactured naloxone 4 milligram nasal spray products 
from 3 to 4 years in 2024; and
Whereas recognizing National Naloxone Awareness Day will contribute to the 
ongoing efforts to educate the public, reduce the stigma associated with 
substance use disorder, and promote access to lifesaving naloxone: Now, 
therefore, be it
Resolved, That the Senate--
(1) designates June 6, 2026, as National Naloxone Awareness 
Day;
(2) recognizes the life-saving benefits of naloxone in 
reversing opioid overdoses and preventing unnecessary deaths;
(3) acknowledges that increased access to naloxone empowers 
individuals, families, healthcare professionals, and first 
responders to intervene in emergency situations and provide 
immediate assistance to those experiencing an opioid overdose;
(4) recognizes that National Naloxone Awareness Day serves 
as an opportunity to educate the public about the importance of 
recognizing the signs of opioid overdose and equipping 
themselves with naloxone to save lives;
(5) encourages Federal, State, and local governments, as 
well as private and nonprofit organizations, to support 
increased naloxone access, education, and distribution efforts; 
and
(6) calls upon Federal agencies, including the Substance 
Abuse and Mental Health Services Administration, the Centers 
for Disease Control and Prevention, the Office of National Drug 
Control Policy, the Drug Enforcement Administration, and all 
others engaged in the National Drug Control Strategy to 
continue supporting public awareness of naloxone, and overdose 
and poisoning prevention.
<all>